Ozempic® (semaglutide) 0.25 mg

Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

as monotherapy when metformin is considered inappropriate due to intolerance or contraindications

In addition to other medicinal products for the treatment of diabetes.

For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied.

Dosage:

Solution for subcutaneous injection in pre-filled pen once weekly